Posttraumatic stress disorder (PTSD) and substance use disorders (SUDs) are commonly co-occurring disorders associated with more adverse consequences than PTSD alone. Prolonged exposure therapy (PE) is one of the most efficacious treatments for PTSD. However, among individuals with PTSD-SUD, 35–62% of individuals drop out of trauma-focused exposure treatments. Thus, it is important to identify predictors of PTSD treatment dropout among substance abusers with PTSD in order to gain information about adapting treatment strategies to enhance retention and outcomes. The current study explored pre-treatment predictors of early termination from PE treatment in a sample of 85 individuals receiving concurrent treatment for PTSD and a SUD in a residential treatment facility as part of a randomized controlled trial. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
The two-year LAAA programme will focus on improving the collection, sharing and use of data between A&E departments, local authorities and the police, and will be supported in developing and implementing their plans by Specialist Support Managers.
They will receive support and expertise in crime prevention, licensing and public health from the Home Office, Public Health England, the Welsh Government and Nightworks, a company that specialises in diversifying the night-time economy.
This article examines an important nursing role in hospital that tries to prevent re-admissions for alcohol-related illnesses. This role has developed over the last 10 years and is now present in most hospitals in England. This article describes a service in a hospital in Islington, London and examines the patient cohort. To read the full article, log in using your NHS OpenAthens details
Plans for reshaped drug and alcohol services aim to ensure that people in the most need will not have to wait for treatment.
The redesigned service will be streamlined to make the best use of available resources, with people classed as ‘high risk’ being accepted on treatment programmes as soon as possible.
The plans will also ensure that the service can cope safely with the number of people in treatment at any given time.
Vulnerable drug users will be given additional support to access treatment services thanks to a new partnership which will see mental health staff work alongside police to take help direct into people’s homes.
From Monday (23 January), nurses from Norfolk and Suffolk NHS Foundation Trust (NSFT) and officers from Norfolk Constabulary will together visit the homes of drug users where there is a suspicion that out-of-county drug dealers have taken over the property.
The data are presented in an interactive tool that allows users to view them in a user-friendly format. The profiles provide a snapshot of the extent of tobacco use, tobacco related harm, and measures being taken to reduce this harm at a local level. These profiles have been designed to help local government and health services to assess the effect of tobacco use on their local populations.
Among youth, the prevalence of mental health and addiction (MHA) disorders is roughly 20%, yet youth are challenged to access evidence-based services in a timely fashion. To address MHA system gaps, this study tests the benefits of an Integrated Collaborative Care Team (ICCT) model for youth with MHA challenges. A rapid, stepped-care approach geared to need in a youth-friendly environment is expected to result in better youth MHA outcomes. Moreover, the ICCT approach is expected to decrease service wait-times, be more youth-friendly and family-friendly, and be more cost-effective, providing substantial public health benefits. Open Access Article
We aimed to assess whether individuals at ultra high risk (UHR) for psychosis have higher rates of cannabis use and cannabis use disorders (CUDs) than non-UHR individuals and determine whether UHR cannabis users have more severe psychotic experiences than non-users. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Alcohol use disorders (AUDs) are common among people with chronic hepatitis C (HCV) and accelerate the development of fibrosis and cirrhosis caused by HCV. Baclofen, a gamma-aminobutyric acid (GABA) beta-receptor agonist, differs from medications for AUDs currently approved by the United States (US) Federal Drug Administration (FDA) as it is metabolized primarily through the kidneys. The primary outcome of this study was to compare baclofen with a placebo in the percentage of days abstinent from alcohol. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
To estimate and test associations between substance use disorders (SUDs) and both completed suicides and suicide attempts in a population with severe mental illness. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Adolescent alcohol misuse is a growing global health concern. Substantial research suggests that parents have an important role in reducing young people's risk for early initiation of alcohol and alcohol-related harms. To facilitate research translation, we conducted a systematic review and meta-analyses of longitudinal studies examining the range of modifiable parenting factors that are associated with adolescent alcohol initiation and levels of later use/misuse. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Buprenorphine-naloxone (BUP-NLX) can be used to manage prescription opioid addiction among persons with chronic pain, but post-treatment relapse is common and difficult to predict. This study estimated whether changes in pain over time and pain volatility during BUP-NLX maintenance would predict opioid use during the taper BUP-NLX taper. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
To examine the efficacy and safety of (1) midazolam-droperidol vs droperidol and (2) midazolam-droperidol vs olanzapine for methamphetamine-related acute agitation. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
People with opioid use disorder (OUD) in prison face an acute risk of death after release. We estimated whether prison-based opioid substitution treatment (OST) reduces this risk. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Commentary to: Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism? Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Disulfiram (DSF) causes the ALDH-mediated deterrence of alcohol consumption. We review recent meta-analyses showing the superior effectiveness of supervised disulfiram (SD) in alcoholism treatment compared with oral naltrexone or acamprosate (ACP). The success of SD is also consistent with the almost complete absence of alcoholism in Japanese homozygotes for ‘inefficient’ ALDH. However, SD is an underused treatment and some clinicians have ethical objections to DSF. We examine these objections and argue that they are based on a misunderstanding of how DSF works. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
To investigate the underlying neurobiology between alcohol use, misuse and dependence and cognitive impairment, particularly Alzheimer's disease (AD). Please contact the library to request a copy of this article - http://bit.ly/1Xyazai